Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity and reactogenicity of a combined adsorbed tetanus toxoid, low dose diphtheria toxoid, five component acellular pertussis and inactivated polio vaccine in six-year-old children.
Diez-Domingo J, Delgado JD, Ballester A, Baldó JM, Planelles MV, Garcés M, Graullera M, Ubeda MI, Sánchez F, Sánchez MM, Azor E, Cabrera A, López F, Alvarez M, San-Martín M, González A, Boisnard F, Thomas S. Diez-Domingo J, et al. Among authors: boisnard f. Pediatr Infect Dis J. 2005 Mar;24(3):219-24. doi: 10.1097/01.inf.0000154339.72774.b0. Pediatr Infect Dis J. 2005. PMID: 15750457 Clinical Trial.
Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine.
Kitchin N, Southern J, Morris R, Borrow R, Fiquet A, Boisnard F, Thomas S, Miller E. Kitchin N, et al. Among authors: boisnard f. Vaccine. 2009 Aug 13;27(37):5096-102. doi: 10.1016/j.vaccine.2009.06.049. Epub 2009 Jun 30. Vaccine. 2009. PMID: 19573637 Clinical Trial.
Immunogenicity and safety of fully liquid DTaP₅-IPV-Hib compared with DTaP₃-IPV/Hib when both coadministered with a heptavalent pneumococcal conjugate vaccine (PCV7) at 2, 3, 4, and 12 to 18 months of age: a phase III, single-blind, randomised, controlled, multicentre study.
Grimprel E, Wysocki J, Boisnard F, Thomas S, Mwawasi G, Reynolds D. Grimprel E, et al. Among authors: boisnard f. Vaccine. 2011 Oct 6;29(43):7370-8. doi: 10.1016/j.vaccine.2011.07.078. Epub 2011 Jul 30. Vaccine. 2011. PMID: 21807056 Clinical Trial.
Safety and immunogenicity of fully liquid DTaP₅-IPV-Hib pediatric combination vaccine (Pediacel®) compared to DTaP₃-HBV-IPV/Hib (Infanrix® Hexa) when coadministered with heptavalent pneumococcal conjugate vaccine (PCV7) as a booster at 11-18 months of age: a phase III, modified double-blind, randomized, controlled, multicenter study.
Berner R, Boisnard F, Thomas S, Mwawasi G, Reynolds D. Berner R, et al. Among authors: boisnard f. Vaccine. 2012 Jul 27;30(35):5270-7. doi: 10.1016/j.vaccine.2012.05.064. Epub 2012 Jun 9. Vaccine. 2012. PMID: 22691430 Clinical Trial.
Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and haemophilus influenzae type b (Hib) vaccine compared with a DTaP3-IPV/Hib vaccine administered at 3, 5, and 12 months of age.
Vesikari T, Silfverdal SA, Boisnard F, Thomas S, Mwawasi G, Reynolds D. Vesikari T, et al. Among authors: boisnard f. Clin Vaccine Immunol. 2013 Oct;20(10):1647-53. doi: 10.1128/CVI.00414-13. Epub 2013 Aug 21. Clin Vaccine Immunol. 2013. PMID: 23966556 Free PMC article. Clinical Trial.
DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers.
Lee AW, Jordanov E, Boisnard F, Marshall GS. Lee AW, et al. Among authors: boisnard f. Expert Rev Vaccines. 2017 Feb;16(2):85-92. doi: 10.1080/14760584.2017.1268920. Epub 2016 Dec 20. Expert Rev Vaccines. 2017. PMID: 27996332 Free article. Review.
19 results